title: [Possibilities of outpatient renoprotective therapy].
abstract: OBJECTIVE
  To show feasibility of conducting nephroprotective therapy in conditions of a municipal diagnostic center.
  
  
  METHODS
  The nephrologist of the city diagnostic center followed up for 2 years 9 patients with different nephropathies comorbid with arterial hypertension, hyperlipidemia and slowly progressive renal failure aged 44-77 years. The course of nephropathy for 1 year before and 1 year after correction with nephroprotective therapy (arterial pressure control and treatment with ACE inhibitors and statins) was analysed.
  
  
  RESULTS
  Before the start of nephroprotective measures all the patients experienced a slow progression of renal failure. After administration of ACE inhibitors in doses lowering arterial pressure not higher than 130/80 mm Hg and statins reducing serum cholesterol nitric residues stopped accumulating while serum creatinine went down after 5 months of the combined treatment.
  
  
  CONCLUSIONS
  It is feasible to conduct a renoprotective policy with a control of therapeutic efficacy in outpatients of a municipal diagnostic center.
authors.forename: I B
authors.initials: IB
authors.lastname: Kolina
authors.forename: E V
authors.initials: EV
authors.lastname: Stavrovskaia
authors.forename: E M
authors.initials: EM
authors.lastname: Shilov
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D018450:Disease Progression; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006977:Hypertension, Renal / Q000209:etiology / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009031:Moscow
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002784:Cholesterol; D003404:Creatinine